+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclandelate Market by Product Type (Branded, Generic), Route Of Administration (Injectable, Oral), Distribution Channel, End User, Application, Dosage Strength - Global Forecast 2025-2030- Product Image
Cyclandelate Market by Product Type (Branded, Generic), Route Of Administration (Injectable, Oral), Distribution Channel, End User, Application, Dosage Strength - Global Forecast 2025-2030- Product Image
Sale

Cyclandelate Market by Product Type (Branded, Generic), Route Of Administration (Injectable, Oral), Distribution Channel, End User, Application, Dosage Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083084
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cyclandelate Market is positioned at a crucial junction as demand patterns shift across global healthcare systems, driven by evolving clinical priorities, regulatory changes, and technological advancements. Senior leaders require actionable intelligence to understand how emerging market dynamics will influence stakeholder strategies and long-term opportunities.

Market Snapshot: Cyclandelate Market Growth Outlook

The Cyclandelate market grew from USD 677.33 million in 2024 to USD 711.11 million in 2025. It is expected to continue expanding at a CAGR of 4.94%, reaching USD 904.94 million by 2030. This trajectory highlights mounting interest in vasodilator therapies and expanding clinical utility across diverse geographies.

Scope & Segmentation

This report delivers comprehensive coverage of the Cyclandelate market, analyzing multiple data-driven segments to reveal high-potential growth areas and track evolving purchasing behaviors.

  • Product Types: Branded, Generic
  • Route of Administration: Injectable (intramuscular, intravenous), Oral (capsule, liquid, tablet)
  • Distribution Channels: Hospital pharmacy, Retail pharmacy, Online pharmacy (third-party platform, website)
  • End Users: Clinics (outpatient clinics, specialty centers), Home care, Hospitals (primary, secondary, tertiary hospitals)
  • Applications: Cerebral vascular disease, Peripheral vascular disease
  • Dosage Strengths: 100 mg, 50 mg
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and additional key countries)
  • Company Coverage: Sandoz International GmbH, Teva Pharmaceuticals International GmbH, Viatris Inc., Fresenius Kabi AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Aurobindo Pharma Ltd.

Key Takeaways for Decision-Makers

  • Innovations in extended-release and injectable Cyclandelate formulations are enhancing clinical flexibility and supporting broader deployment across therapy settings.
  • Healthcare provider adoption is being shaped by integration of digital patient adherence technologies and remote health monitoring, linking therapeutic delivery with behavioral insights.
  • Manufacturers and distributors are recalibrating their procurement and production models in line with regulatory shifts, particularly in regions with tariff adjustments or evolving compliance requirements.
  • Growth strategies are increasingly focused on expanding outpatient, home care, and specialty clinic applications, reflecting overall shifts from hospital-centric to more decentralized care.
  • Effective differentiation now demands robust pharmacoeconomic evidence and real-world data to demonstrate value to payers amidst heightened reimbursement scrutiny.
  • Strategic partnerships with regional distributors, contract manufacturers, and local authorities are facilitating faster market entry and improved alignment with national formularies and coverage protocols.

Tariff Impact and Supply Chain Strategies

In the United States, 2025 tariff policies are influencing Cyclandelate’s end-to-end supply chain. Increased duties on imported active pharmaceutical ingredients are prompting stakeholders to consider nearshoring, revisit supplier terms, and invest in domestic synthesis capabilities. These changes affect overall cost structures and could shift pricing strategies, contract negotiations, and even influence access at the reimbursement and formulary stages. Industry leaders are actively engaging with policymakers and adjusting inventory planning to maintain continuity and manage exposure.

Cyclandelate Market Methodology & Data Sources

This research utilizes a multi-tiered methodology that includes interviews with industry experts, analysis of regulatory filings, literature review, and evaluation of proprietary and public databases. Data collection covers input from pharmaceutical manufacturers, key opinion leaders, contract service providers, and payers. The insights are validated through external advisory panels, ensuring credibility for market sizing, segmentation, and trend analysis.

Why This Report Matters

  • Enables executives to identify high-value segments, align investment plans, and respond nimbly to regulatory and market shifts affecting Cyclandelate adoption.
  • Delivers clarity on evolving supply chain models, pricing paradigms, and regional market access levers in the context of competitive and economic pressures.
  • Supports strategic planning by combining granular segmentation with actionable competitive intelligence and robust methodological transparency.

Conclusion

The Cyclandelate market is transforming, propelled by shifts in clinical demand, regulatory oversight, and global supply dynamics. Stakeholders prepared to adapt to these changes will be best positioned to capture sustainable value in the evolving vascular therapeutics landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing off-label use of cyclandelate for diabetic microvascular complications in outpatient clinics
5.2. Integration of cyclandelate therapy with digital health monitoring devices for personalized vascular treatment plans
5.3. Surging research into cyclandelate combination formulations to enhance vasodilatory effects and patient adherence
5.4. Expansion of cyclandelate production capacity in Asia-Pacific to meet growing demand for peripheral circulatory disorder treatments
5.5. Impact of evolving pharmacovigilance regulations on cyclandelate safety monitoring and adverse event reporting requirements
5.6. Shifting reimbursement policies favoring generic cyclandelate in European healthcare systems to optimize treatment affordability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cyclandelate Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Cyclandelate Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral
9.3.1. Capsule
9.3.2. Liquid
9.3.3. Tablet
10. Cyclandelate Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Third-Party Platform
10.3.2. Website
10.4. Retail Pharmacy
11. Cyclandelate Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Outpatient Clinics
11.2.2. Specialty Centers
11.3. Home Care
11.4. Hospitals
11.4.1. Primary Hospitals
11.4.2. Secondary Hospitals
11.4.3. Tertiary Hospitals
12. Cyclandelate Market, by Application
12.1. Introduction
12.2. Cerebral Vascular Disease
12.3. Peripheral Vascular Disease
13. Cyclandelate Market, by Dosage Strength
13.1. Introduction
13.2. 100 Mg
13.3. 50 Mg
14. Americas Cyclandelate Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cyclandelate Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cyclandelate Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sandoz International GmbH
17.3.2. Teva Pharmaceuticals International GmbH
17.3.3. Viatris Inc.
17.3.4. Fresenius Kabi AG
17.3.5. Dr. Reddy’s Laboratories Ltd.
17.3.6. Sun Pharmaceutical Industries Ltd.
17.3.7. Lupin Ltd.
17.3.8. Cipla Ltd.
17.3.9. Hikma Pharmaceuticals PLC
17.3.10. Aurobindo Pharma Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CYCLANDELATE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CYCLANDELATE MARKET: RESEARCHAI
FIGURE 28. CYCLANDELATE MARKET: RESEARCHSTATISTICS
FIGURE 29. CYCLANDELATE MARKET: RESEARCHCONTACTS
FIGURE 30. CYCLANDELATE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYCLANDELATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYCLANDELATE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYCLANDELATE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYCLANDELATE MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYCLANDELATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYCLANDELATE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYCLANDELATE MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYCLANDELATE MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYCLANDELATE MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYCLANDELATE MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYCLANDELATE MARKET SIZE, BY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYCLANDELATE MARKET SIZE, BY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYCLANDELATE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYCLANDELATE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYCLANDELATE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYCLANDELATE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYCLANDELATE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYCLANDELATE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CYCLANDELATE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CYCLANDELATE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CYCLANDELATE MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CYCLANDELATE MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CYCLANDELATE MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CYCLANDELATE MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CYCLANDELATE MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CYCLANDELATE MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CYCLANDELATE MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CYCLANDELATE MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CYCLANDELATE MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CYCLANDELATE MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 136. CANADA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 138. CANADA CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 139. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. CANADA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. CANADA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. CANADA CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. CANADA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. CANADA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. CANADA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. GERMANY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. GERMANY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. GERMANY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. FRANCE CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FRANCE CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. FRANCE CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. FRANCE CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. FRANCE CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. FRANCE CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 308. FRANCE CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 331. ITALY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. ITALY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. ITALY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. ITALY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. ITALY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 336. ITALY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 337. ITALY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 338. ITALY CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 339. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. ITALY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 342. ITALY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 343. ITALY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. ITALY CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. ITALY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 346. ITALY CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 347. ITALY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 348. ITALY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 349. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. ITALY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 352. ITALY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 353. SPAIN CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 354. SPAIN CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 355. SPAIN CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 356. SPAIN CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 357. SPAIN CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 358. SPAIN CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 359. SPAIN CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 360. SPAIN CYCLANDELATE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 361. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. SPAIN CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 364. SPAIN CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 365. SPAIN CYCLANDELATE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 366. SPAIN CYCLANDELATE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 367. SPAIN CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 368. SPAIN CYCLANDELATE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 369. SPAIN CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 370. SPAIN CYCLANDELATE MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cyclandelate market report include:
  • Sandoz International GmbH
  • Teva Pharmaceuticals International GmbH
  • Viatris Inc.
  • Fresenius Kabi AG
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Ltd.
  • Cipla Ltd.
  • Hikma Pharmaceuticals PLC
  • Aurobindo Pharma Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 711.11 Million
Forecasted Market Value ( USD ) by 2030 $ 904.94 Million
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cyclandelate (CAS 456-59-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cyclandelate (CAS 456-59-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
a-Acetyldigitoxin Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User (Clinics, Home Care, Hospitals), Dosage Form, Route Of Administration, Application - Global Forecast 2025-2030 - Product Image

a-Acetyldigitoxin Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User (Clinics, Home Care, Hospitals), Dosage Form, Route Of Administration, Application - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Angina Pectoris Drugs Market by Drug Class (Ace Inhibitors, Antiplatelet Agents, Beta Blockers), Dosage Form (Capsule, Injection, Patch), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Angina Pectoris Drugs Market by Drug Class (Ace Inhibitors, Antiplatelet Agents, Beta Blockers), Dosage Form (Capsule, Injection, Patch), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of Administration (Oral, Parenteral), By Distribution Channel, By Region, and Segment Forecasts, 2025 - 2030 - Product Image

Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of Administration (Oral, Parenteral), By Distribution Channel, By Region, and Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From

About the Cyclandelate Market

Cyclandelate is a cardiovascular drug used to treat peripheral vascular disease, a condition in which the blood vessels in the legs become narrowed and hardened. It works by dilating the blood vessels, allowing more blood to flow through them and reducing the symptoms of the disease. Cyclandelate is available in both oral and topical forms, and is often used in combination with other medications to treat the condition. Cyclandelate is a widely used drug in the cardiovascular market, with many pharmaceutical companies producing and marketing it. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.